200 related articles for article (PubMed ID: 11070113)
1. Steatosis in donor and transplant liver biopsies.
Crowley H; Lewis WD; Gordon F; Jenkins R; Khettry U
Hum Pathol; 2000 Oct; 31(10):1209-13. PubMed ID: 11070113
[TBL] [Abstract][Full Text] [Related]
2. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
3. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
4. Expanding postmortem donor pool using steatotic liver grafts: a new look.
Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
[TBL] [Abstract][Full Text] [Related]
5. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
6. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation.
Ryan CK; Johnson LA; Germin BI; Marcos A
Liver Transpl; 2002 Dec; 8(12):1114-22. PubMed ID: 12474149
[TBL] [Abstract][Full Text] [Related]
7. Donor liver steatosis and graft selection for liver transplantation: a short review.
Angelico M
Eur Rev Med Pharmacol Sci; 2005; 9(5):295-7. PubMed ID: 16231593
[TBL] [Abstract][Full Text] [Related]
8. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
9. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation.
Nikeghbalian S; Nejatollahi SM; Salahi H; Bahador A; Sabet B; Jalaeian H; Geramizadeh B; Dehghani SM; Malek-Hosseini SA
Transplant Proc; 2007 May; 39(4):1181-3. PubMed ID: 17524926
[TBL] [Abstract][Full Text] [Related]
10. An approach to the rational use of steatotic donor livers in liver transplantation.
Urena MA; Moreno Gonzalez E; Romero CJ; Ruiz-Delgado FC; Moreno Sanz C
Hepatogastroenterology; 1999; 46(26):1164-73. PubMed ID: 10370686
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
13. The clinical associations with hepatic steatosis: a retrospective study.
Samarasinghe D; Tasman-Jones C
N Z Med J; 1992 Feb; 105(928):57-8. PubMed ID: 1542474
[TBL] [Abstract][Full Text] [Related]
14. Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters.
Cieślak B; Lewandowski Z; Urban M; Ziarkiewicz-Wróblewska B; Krawczyk M
Transplant Proc; 2009 Oct; 41(8):2985-8. PubMed ID: 19857657
[TBL] [Abstract][Full Text] [Related]
15. Donor liver dysfunction: application of a new scoring system to identify the marginal donor.
Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Fonseca LE; Motta TD; Pandullo FL; Rezende MB; Meira-Filho SP; Sá JR; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2516-8. PubMed ID: 17954162
[TBL] [Abstract][Full Text] [Related]
16. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation.
Sharkey FE; Lytvak I; Prihoda TJ; Speeg KV; Washburn WK; Halff GA
Hum Pathol; 2011 Sep; 42(9):1337-42. PubMed ID: 21420717
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
[TBL] [Abstract][Full Text] [Related]
18. Use of steatotic graft in living-donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
[TBL] [Abstract][Full Text] [Related]
19. [Steatosis and nonalcoholic steatohepatitis. A comparative analysis].
Piñol V; Bessa X; Bruguera M; Rodés J
Gastroenterol Hepatol; 2000 Feb; 23(2):57-61. PubMed ID: 10726383
[TBL] [Abstract][Full Text] [Related]
20. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]